News, Analysis & Insights on Nutrition, Supplements, and Health
Industry has welcomed yesterday’s European Commission decision to halt publication of article 13.1 health claim opinions in batches, as well as temporarily removing botanicals from the process, but warns fundamental problems with the legislation remain.
The Federal Trade Commission legal action alleging POM Wonderful made unsubstantiated claims for its pomegranate products, adds to a stream of claim actions the increasingly active agency has taken this year.
The nutritional premix manufacturer Fortitech is to sell a stake in its business to a private equity firm in the hope of boosting its expansion efforts in global markets.
The incidence of celiac disease has doubled every 15 years since 1974 and is becoming more prevalent in the elderly, claims new research from the University of Maryland’s Center for Celiac Research.
EFSA health claim opinion
The European Food Safety Authority (EFSA) has rejected an article 13.5, gut health claim for a proprietary, two-strain, probiotic product manufactured by Italian firm, Synbiotec.
Some pine-bark extracts may have no effect in lowering blood pressure or reducing other risk factors for heart disease, according to researchers at Stanford University School of Medicine, but extrapolation to the whole sector is unwarranted.
Once upon a time sugar was sugar, and sugar was most definitely not good for you. So the Corn Refiners Association move to rebrand high fructose corn syrup as corn sugar is a daring move – but should do little to sweeten its reputation.